MedTrace Logo

Maternal Newborn Health Registry

NCT01073475 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 950000

Last updated 2026-01-21

No results posted yet for this study

Summary

The primary purpose of this population-based study is to quantify and understand the trends in pregnancy outcomes in defined low-resource geographic areas over time, in order to provide population-based data on stillbirths, neonatal and maternal mortality.

Conditions

  • Pregnancy Outcome Trends in Low-resource Geographic Areas

Interventions

OTHER

There is no intervention associated with the parent MNHR study. For the MNHR COVID sub-study, participants will be asked to provide a blood specimen at or near delivery.

There is no intervention associated with the parent MNHR study For the MNHR COVID sub-study, each woman will be asked to provide a blood specimen of approximately 3-5 cc at or near delivery (at delivery or 14 days after) to be tested for COVID-19 antibodies. The person collecting the specimen will be a trained member of the registry staff. The ZEUS ELISA SARS-CoV-2 IgG Test System will be used and run at each site. RTI International will provide central quality support of the analyses.

Sponsors & Collaborators

  • NICHD Global Network for Women's and Children's Health

    lead NETWORK

Principal Investigators

  • Marion Koso-Thomas, MD · Center for Research for Mothers and Children (NICHD)

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2030-01-31
Completion
2030-05-31

Countries

  • United States
  • Bangladesh
  • Democratic Republic of the Congo
  • Guatemala
  • India
  • Pakistan
  • Zambia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01073475 on ClinicalTrials.gov